This Article Full Text Full Text (PDF) Supplemental Research Data All Versions of this Article: gr.6783507v1 17/11/1550    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xu, X. Articles by Farnham, P. J. Search for Related Content PubMed PubMed Citation Articles by Xu, X. Articles by Farnham, P. J. Social Bookmarking                   What's this?

A comprehensive ChIP–chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members

¹ Department of Pharmacology and the Genome Center, University of California-Davis, Davis, California 95616, USA; ² University of Wisconsin Medical School, Madison, Wisconsin, 53705 USA; ³ NimbleGen Systems Inc., Madison, Wisconsin, 53711 USA

Using ChIP–chip assays (employing ENCODE arrays and core promoter arrays), we examined the binding patterns of three members of the E2F family in five cell types. We determined that most E2F1, E2F4, and E2F6 binding sites are located within 2 kb of a transcription start site, in both normal and tumor cells. In fact, the majority of promoters that are active (as defined by TAF1 or POLR2A binding) in GM06990 B lymphocytes and Ntera2 carcinoma cells were also bound by an E2F. This very close relationship between E2F binding sites and binding sites for general transcription factors in both normal and tumor cells suggests that a chromatin-bound E2F may be a signpost for active transcription initiation complexes. In general, we found that several E2Fs bind to a given promoter and that there is only modest cell type specificity of the E2F family. Thus, it is difficult to assess the role of any particular E2F in transcriptional regulation, due to extreme redundancy of target promoters. However, Ntera2 carcinoma cells were exceptional in that a large set of promoters were bound by E2F6, but not by E2F1 or E2F4. It has been proposed that E2F6 contributes to gene silencing by recruiting enzymes involved in methylating histone H3. To test this hypothesis, we created Ntera2 cell lines harboring shRNAs to E2F6. We found that reduction of E2F6 only induced minimal alteration of the transcriptome of Ntera2 transcriptome. Our results support the concept of functional redundancy in the E2F family and suggest that E2F6 is not critical for histone methylation.

E-mail pjfarnham{at}ucdavis.edu; fax (530) 754-9658.

[Supplemental material is available online at www.genome.org. The ChIP–chip data has been deposited as GEO series GSE8716.]

Article published online before print. Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.6783507

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Rada-Iglesias, A. Ameur, P. Kapranov, S. Enroth, J. Komorowski, T. R. Gingeras, and C. Wadelius Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders Genome Res., March 1, 2008; 18(3): 380 - 392. [Abstract] [Full Text] [PDF]